Alkermes News, Alkermes Quote, ALKS Quote

Alkermes (NQ:ALKS) Delayed: 46.10 -0.78 (1.66%)

Prev. Close

$46.88

Today 6M 1Y 5Y

Open

$46.14

52 Wk High

$80.71

52 Wk Low

$27.14

Day High

$46.93

Day Low

$45.80

P/E

354.62

EPS

$0.13

Volume

1,064,035

Friends, Peers and Foes (?): AVDL, CNTA, BHVN, AMGN, AXSM (more...)

ALERTS | RSS

Sep 1, 2026 03:55 AM Mizuho Reiterates Outperform Rating on Alkermes (ALKS)
Aug 24, 2026 06:30 PM Alkermes narcolepsy drug data published in The Lancet Neurology
Aug 24, 2026 06:30 PM The Lancet Neurology Publishes Data From Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 1
Aug 17, 2026 06:54 PM Form 4 Alkermes plc. For: Aug 17 Filed by: Nichols Christian Todd
Aug 17, 2026 04:50 PM Form 144 Alkermes plc. Filed by: Nichols Christian Todd
Aug 12, 2026 11:03 AM Form 4 Alkermes plc. For: Aug 03 Filed by: snyderman nancy lynn MD
Aug 12, 2026 11:03 AM Form 4 Alkermes plc. For: Aug 03 Filed by: Hopkinson Craig C.
Aug 12, 2026 11:03 AM Form 4 Alkermes plc. For: Aug 03 Filed by: Gaffin David Joseph
Aug 12, 2026 09:27 AM Form 8-K Alkermes plc. For: Aug 12
Aug 7, 2026 09:17 PM Form 4 Alkermes plc. For: Aug 05 Filed by: Jackson Blair Curtis

Entities mentioned with ALKS

View All Entities